ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för tetradecanoic acid. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

16 träffar

Bibliografisk träff 2017-06-09

IgM-mediated autoimmune responses to oxidative specific epitopes, but not nitrosylated adducts, are significantly decreased in pregnancy: association with bacterial translocation, perinatal and lifetime major depression and the tryptophan catabolite (TRYCAT) pathway.

Roomruangwong C, Kanchanatawan B, Sirivichayakul S, Anderson G, Carvalho AF, Duleu S, Geffard M, Maes M.

Metab Brain Dis · research support, non-u.s. gov't; journal article · DOI 10.1007/s11011-017-0040-2

Bibliografisk träff 2016-05-20

Myristic Acid Enhances Diacylglycerol Kinase δ-Dependent Glucose Uptake in Myotubes.

Wada Y, Sakiyama S, Sakai H, Sakane F.

Lipids · research support, non-u.s. gov't; journal article · DOI 10.1007/s11745-016-4162-9

Bibliografisk träff 2011-10-26

Diets high in palmitic acid (16:0), lauric and myristic acids (12:0 + 14:0), or oleic acid (18:1) do not alter postprandial or fasting plasma homocysteine and inflammatory markers in healthy Malaysian adults.

Voon PT, Ng TK, Lee VK, Nesaretnam K.

Am J Clin Nutr · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.3945/ajcn.111.020107

Bibliografisk träff 2011-09-29

The use of myristic acid as a ligand of polyethylenimine/DNA nanoparticles for targeted gene therapy of glioblastoma.

Li J, Gu B, Meng Q, Yan Z, Gao H, Chen X, Yang X, Lu W.

Nanotechnology · research support, non-u.s. gov't; journal article · DOI 10.1088/0957-4484/22/43/435101

Bibliografisk träff 2010-10-01

Regulation of mammalian desaturases by myristic acid: N-terminal myristoylation and other modulations.

Rioux V, Pédrono F, Legrand P.

Biochim Biophys Acta · review; journal article · DOI 10.1016/j.bbalip.2010.09.005

Bibliografisk träff 2010-07-01

Final report of the amended safety assessment of myristic acid and its salts and esters as used in cosmetics.

Becker LC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Marks JG, Shank RC, Slaga TJ, Snyder PW, Alan Andersen F.

Int J Toxicol · research support, non-u.s. gov't; review; journal article · DOI 10.1177/1091581810374127

Bibliografisk träff 2009-12-02

The serum fatty acids myristic acid and linoleic acid are better predictors of serum cholesterol concentrations when measured as molecular percentages rather than as absolute concentrations.

Bradbury KE, Skeaff CM, Green TJ, Gray AR, Crowe FL.

Am J Clin Nutr · research support, non-u.s. gov't; journal article · DOI 10.3945/ajcn.2009.28159

Bibliografisk träff 2009-10-28

Myristic Acid, A Side Chain of Phorbol Myristate Acetate (PMA), Can Activate Human Polymorphonuclear Leukocytes to Produce Oxygen Radicals More Potently than PMA.

Tada M, Ichiishi E, Saito R, Emoto N, Niwano Y, Kohno M.

J Clin Biochem Nutr · research-article; journal article · DOI 10.3164/jcbn.09-30

Bibliografisk träff 2009-09-26

Lauric acid and myristic acid prevent testosterone induced prostatic hyperplasia in rats.

Veeresh Babu SV, Veeresh B, Patil AA, Warke YB.

Eur J Pharmacol · journal article · DOI 10.1016/j.ejphar.2009.09.037

Bibliografisk träff 2009-09-15

Inhibition of carboxylesterase activity of THP1 monocytes/macrophages and recombinant human carboxylesterase 1 by oxysterols and fatty acids.

Crow JA, Herring KL, Xie S, Borazjani A, Potter PM, Ross MK.

Biochim Biophys Acta · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1016/j.bbalip.2009.09.002

Bibliografisk träff 2009-01-01

[New regulatory and signal functions for myristic acid].

Beauchamp E, Rioux V, Legrand P.

Med Sci (Paris) · review; journal article; english abstract · DOI 10.1051/medsci/200925157

Bibliografisk träff 2006-03-22

Design, synthesis, antibacterial, and QSAR studies of myristic acid derivatives.

Narasimhan B, Mourya V, Dhake A.

Bioorg Med Chem Lett · journal article · DOI 10.1016/j.bmcl.2006.02.056

Bibliografisk träff 2006-03-01

Lipolanthionine peptides act as inhibitors of TLR2-mediated IL-8 secretion. Synthesis and structure-activity relationships.

Seyberth T, Voss S, Brock R, Wiesmüller KH, Jung G.

J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/jm050585d

Bibliografisk träff 2004-06-01

Long chain amines and long chain ammonium salts as novel inhibitors of dynamin GTPase activity.

Hill TA, Odell LR, Quan A, Abagyan R, Ferguson G, Robinson PJ, McCluskey A.

Bioorg Med Chem Lett · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmcl.2004.03.096

Bibliografisk träff 2003-09-01

Methane-suppressing effect of myristic acid in sheep as affected by dietary calcium and forage proportion.

Machmüller A, Machmüller A, Soliva CR, Kreuzer M.

Br J Nutr · comparative study; journal article · DOI 10.1079/bjn2003932

Bibliografisk träff 1982-03-01

Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.

Yasuda Y, Tochikubo K, Hachisuka Y, Tomida H, Ikeda K.

J Med Chem · journal article · DOI 10.1021/jm00345a016